MedPage Today on MSN
Tranexamic acid reduces major bleeding in urologic surgery
Prior results with the drug in other surgical settings have been mixed ...
"Our cohort of CLL patients on ibrutinib had a two-times greater risk of bleeding complications relative to those on anticoagulants and a nearly 40-times greater risk of bleeding complications ...
Little is known about the risk of bleeding in patients with bleeding disorders who undergo major surgeries or outcomes for those managed perioperatively at hemophilia treatment centers. With ...
Postoperative bleeding is one of the most common complications after cardiac surgeries, especially in open heart ones. In this kind of surgery, surgeons need to resort to cardiopulmonary bypass, an ...
Please provide your email address to receive an email when new articles are posted on . Patients who received apixaban or rivaroxaban after cardiac surgery were no more likely to experience major ...
Tranexamic acid (TXA) failed to reduce the need for red blood cell (RBC) transfusion following surgery for liver cancer, including colorectal liver metastases, the placebo-controlled HeLiX trial ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Tranexamic acid administered intravenously before and after noncardiac surgery lowered the risk for ...
The use of adjunctive topical tranexamic acid (TXA) showed benefits in significantly reducing postoperative bleeding with second intention healing, or allowing wounds to heal naturally without sutures ...
Patients undergoing noncardiac surgery who received a single dose of tranexamic acid (TXA), which promotes blood clotting, at the beginning and end of their surgery had significantly less serious ...
The 30-day mortality rate after emergent abdominal surgery is twice as high for patients on dialysis who experience major bleeding. Patients on dialysis experience high rates of bleeding requiring ...
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results